[1] |
Chan SC,Chang JT,Wang HM et al.Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma:the role of standardized uptake value[J].Oral Oncol,2009,45(1):52-8.
|
[2] |
Gould MK,Kuschner WG,Rydzak CE,et al.Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer:a meta-analysis[J].Ann Intern Med,2003,139 (11):879-92.
|
[3] |
Hong IK,Kim JH,Ra YS,et al.Diagnostic usefulness of 3′-deoxy-3′-[(18)F]fluorothymidine positron emission tomography in recurrent brain tumor [J].J Comput Assist Tomogr,2011,35(6):679-84.
|
[4] |
Liu X,Zhou NK,Zhang JM,et al.Experimental study on biodistribution and PET imaging of 3′-deoxy-3′-18F- fluorothymidine in murine models of lung carcinoma and inflammation[J].Di San Jun Yi Da Xue Xue Bao,2007,29 (9):798-800.[柳曦,周乃康,张锦明,等.18F-FLT在小鼠肺癌和炎症模型中的生物分布及PET显像研究进展[J].第三军医大学学 报,2007,29(9):798-800.]
|
[5] |
van Waarde A,Cobben DC,Suumeijer AJ,et al.Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model[J].J Nucl Med,2004,45(4):695-700.
|
[6] |
Yamamoto Y,Nishiyama Y,Ishikawa S,et al.3′-Deoxy-3′-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors:comparison with 2-deoxy-2-18f-fluoro-D-glucose[J].J Compute Assist Tomogr,2008,32 (3):432-7.
|
[7] |
Yen TC,Chang YC,Chan SC,et al.Are dual-phase 18F-FDG PET scans necessary in nasopharygeal carcinoma to assess the primary tumour and loco-regional nodes? [J].Eur J Nucl Med Mol Imaging,2005,32(5):541-8.
|
[8] |
Shim SS,Lee KS,Kim BT,et al.Non-small cell lung cancer:prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging[J].Radiology,2005,236(3):1011-9.
|
[9] |
Pauls S,Buck AK,Hohl K,et al.Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F- FDG PET/CT[J].Nuklearmedizin,2007,46(1):9-14.
|
[10] |
Wang JP,Zai XM,Qing SB,et al.Application value of 18F-FLT PET/CT fusion imaging in the different carcinomas[ J].Jiangsu Yi Yao,2011,37(9):1056-8.[王建平,翟小明,秦颂兵,等.18F-FLT PET/CT显像在恶性肿瘤诊断中的应用[J].江苏医 药,2011,37(9):1056-8.]
|
[11] |
De Leyn P,Stroobants S,De Wever W,et al.Prospective comparative study of integrated positron emission tomographycomputed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer:a Leuven Lung Cancer Group Study[J].J Clin Oncol,2006,24(21):3333-9.
|
[12] |
Tian J,Yang X,Yu L,et al.A multicenter clinical trial on the diagnostic value of dual-tracer PET-CT in pulmonary lesions using 3′-deoxy-3′-18F-fluorothymidine and 18F-FDG[J].J Nucl Med,2008,49(2):186-94.
|
[13] |
Lee SW,Nam SY,Im KC,et al.Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2- deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas [J].Radiother Oncol,2008,87(2):211-6.
|
[14] |
Seltzer MA,Yap CS,Silverman DH,et al.The impact of PET on the management of lung cancer:the referring physician′s perspective [J].J Nucl Med,2002,43(6):752-6.
|